Farmakologi for sygeplejersker

Evidensbaseret sygepleje om medicinske sygdommeMedicinske sygdomme og evidensbaseret sygepleje er det nutidige og gennemgribende standardværk, som forener sygdomslære og sygepleje. Bogen er både en grundbog og opslagsbog med sygeplejestuderende og sygeplejersker som målgruppe.I takt med bedre sygdomsdiagnostik, befolkningens øgede levetid, flere patienter med multisygdomme og et krav om evidensbaseret sygepleje står sygeplejersker i både primær og sekundær sektor overfor nye udfordringer. Sygeplejersker skal kunne drage omsorg, udføre sygeplejehandlinger, forebygge, behandle, lindre symptomer og kunne undervise/vejlede patienter. Det kræver en omfattende og opdateret viden om sygdomslære for at kunne udføre sygeplejeinterventioner, træffe kliniske beslutninger, varetage klinisk lederskab og samarbejde med patienten.Medicinske sygdomme og evidensbaseret sygepleje tilbyder 23 kapitler skrevet af læger og/eller kliniske sygeplejespecialister med indgående erfarings- og forskningsmæssige tilgang til specialerne.

Radiopharmaceuticals - Current Research for Better Diagnosis and Therapy discusses the importance of radiopharmaceuticals and their environmental, pharmaceutical, diagnostic, therapeutic, and research applications. Chapters address such topics as the fundamentals of radiopharmaceutical chemistry and preparation, fabrication, materials manipulation, and characterization of radiopharmaceuticals, applications of radiopharmaceuticals in preclinical studies, radiopharmaceuticals in modern cancer therapy, and new trends in preparation, biodistribution, and pharmacokinetics of radiopharmaceuticals in diagnosis and research.

Introduced in the 1980s, biologic medications have since become important tools in modern medicine. However, biologics are expensive, greatly affecting the healthcare budgets of both underdeveloped and developed countries. Fortunately, biosimilars, which are highly similar, reverse-engineered versions of existing biological medicines and their active ingredients, are now available as more affordable options for patients treated with biologics. This book discusses biosimilars with chapters on clinical trials, regulation, pharmacovigilance, and the interchangeability of biosimilars with biologics. It also addresses future trends in the biosimilars market.

This book focuses on various aspects and applications of drug repurposing, the understanding of which is important for treating diseases. Due to the high costs and time associated with the new drug discovery process, the inclination toward drug repurposing is increasing for common as well as rare diseases. A major focus of this book is understanding the role of drug repurposing to develop drugs for infectious diseases, including antivirals, antibacterial and anticancer drugs, as well as immunotherapeutics.

The book focuses on various aspects and properties of high-throughput screening (HTS), which is of great importance in the development of novel drugs to treat communicable and non-communicable diseases. Chapters in this volume discuss HTS methodologies, resources, and technologies and highlight the significance of HTS in personalized and precision medicine.

Vaccination is the most effective and scientifically based means of protection against infectious diseases, especially in this era of the COVID-19 pandemic. This book examines several issues related to the development of vaccines against viral, bacterial, and parasitic infections.

Presents an overview of non-medical prescribing by health professions other than doctors and covers the ethics, legal and patient safety framework. This book includes background information on history, competencies needed (includes RPSGB guidelines) and the moral aspects of prescribing.